Cargando…

Outcomes in pulmonary sarcoidosis: results of a newly implemented prednisone protocol

BACKGROUND AND AIM: Prednisone is used as first-line therapy for patients with pulmonary sarcoidosis. There is however no clear association between prednisone dose and FVC change in patients with pulmonary sarcoidosis. In order to improve our standard of care we introduced a more conservative predni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kampstra, Nynke A, van der Wees, Philip J, van Beek, Frouke, Biesma, Douwe H, Grutters, Jan C., van der Nat, Paul B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099653/ https://www.ncbi.nlm.nih.gov/pubmed/36975054 http://dx.doi.org/10.36141/svdld.v40i1.13574

Ejemplares similares

Patterns of healthcare resource utilization in patients with sarcoidosis: a cross-sectional study
por: Kampstra, Nynke A., et al.
Publicado: (2020)

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative
por: Kampstra, Nynke A, et al.
Publicado: (2019)

Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes
por: Kampstra, Nynke A., et al.
Publicado: (2019)

ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis Patients
por: Karakaya, Bekir, et al.
Publicado: (2022)

Health outcomes measurement and organizational readiness support quality improvement: a systematic review
por: Kampstra, Nynke A., et al.
Publicado: (2018)

Five years’ experience with value-based quality improvement teams: the key factors to a successful implementation in hospital care
por: Daniels, Kirsten, et al.
Publicado: (2022)

No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis
por: Hoffman, Thijs W., et al.
Publicado: (2023)

The Intervention Selection Toolbox to improve patient-relevant outcomes: an implementation and qualitative evaluation study in colorectal cancer surgery
por: Smalbroek, Bo, et al.
Publicado: (2023)

Identifying a core outcome set for pulmonary sarcoidosis research – the Foundation for Sarcoidosis Research – Sarcoidosis Clinical OUtcomes Taskforce (SCOUT)
por: Harman, Nicola L., et al.
Publicado: (2022)

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

Scout – sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis
por: Harman, Nicola L, et al.
Publicado: (2021)

Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension
por: Groen, Karlijn, et al.
Publicado: (2022)

Establishing a Diagnosis of Pulmonary Sarcoidosis
por: Grutters, Jan C.
Publicado: (2023)

Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis
por: Daniels, K., et al.
Publicado: (2020)

Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
por: Schimmelpennink, M. C., et al.
Publicado: (2022)

Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine
por: Pereira, Eduardo Guimarães, et al.
Publicado: (2016)

Pulmonary hypertension complicating pulmonary sarcoidosis
por: Huitema, M. P., et al.
Publicado: (2016)

Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis
por: Hoffman, T. W., et al.
Publicado: (2022)

How to Use Lean Thinking for the Optimization of Clinical Pathways: A Systematic Review and a Proposed Framework to Analyze Pathways on a System Level
por: Vijverberg, Joanna R. G., et al.
Publicado: (2023)

Mapping the extent, range and nature of research activity on value-based healthcare in the 15 years following its introduction (2006–2021): a scoping review
por: Vijverberg, Joanna R G, et al.
Publicado: (2022)

A case of facial atrophic sarcoidosis in an adolescent, successfully treated with the combination of prednisone and hydroxychloroquine()()
por: Zhu, Xiaomei, et al.
Publicado: (2020)

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population
por: Kahlmann, Vivienne, et al.
Publicado: (2021)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

Prednisone: Pulmonary histoplasmosis: case report
Publicado: (2017)

Granuloma Formation in Pulmonary Sarcoidosis
por: Broos, Caroline E., et al.
Publicado: (2013)

Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients
por: van der Leeuw, Matthijs S., et al.
Publicado: (2023)

COACH2MOVE: THE STORY OF IMPLEMENTING A PERSON-CENTERED PHYSICAL THERAPY APPROACH IN CLINICAL PRACTICE
por: Heij, Ward, et al.
Publicado: (2022)

ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis
por: Lingner, Heidrun, et al.
Publicado: (2015)

Cryptococcal meningitis complicating sarcoidosis
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative
por: Reesink, Daan J., et al.
Publicado: (2021)

The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
por: Mathijssen, H., et al.
Publicado: (2021)

Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis
por: Fritz, Daan, et al.
Publicado: (2021)

BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity
por: Danila, Edvardas, et al.
Publicado: (2009)

Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with Sarcoidosis
por: Kraaijvanger, Raisa, et al.
Publicado: (2023)

Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
por: Mathijssen, H., et al.
Publicado: (2020)

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)
por: Seefat, M.R., et al.
Publicado: (2023)

Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy
por: Vorselaars, Adriane D. M., et al.
Publicado: (2013)

The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review
por: Vis, Roeland, et al.
Publicado: (2020)

Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype
por: Beijer, Els, et al.
Publicado: (2021)

In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
por: Keijsers, Ruth G.M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ob1m5mllrqr7m5dmo82kks6oaa